Werewolf Therapeutics (HOWL) Price-to-Earnings (P/E) Ratio
Price: $0.8829
Market Cap: $39.58M
Avg Volume: 258.54K
Market Cap: $39.58M
Avg Volume: 258.54K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Werewolf Therapeutics's P/E ratios across different time periods:
- TTM: -0.56
- Annual: -0.91
- Quarterly: -0.81
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 0.87
- Price-to-Sales (P/S) Ratio: 34.02
Annual Ratios
Werewolf Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-0.56
P/B Ratio (Annual)
0.87
P/S Ratio (Annual)
34.02
Werewolf Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -0.91 | 0.87 | 34.02 |
| 2023 | -3.68 | 1.24 | 6.90 |
| 2022 | -1.15 | 0.48 | 3.61 |
| 2021 | -6.54 | 2.13 | 0.00 |
| 2020 | -30.89 | -8.90 | 0.00 |
| 2019 | -41.99 | -18.99 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for HOWL.